Department of Hematology and Oncology, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
Leuk Res. 2012 Jun;36(6):704-8. doi: 10.1016/j.leukres.2011.12.003. Epub 2012 Jan 5.
The present study was performed to establish the prevalence of the recurrent fusion transcripts in Argentinean pediatric patients with acute lymphoblastic leukemia (ALL). A total of 380 newly diagnosed children (including 50 infants and 44 T-ALL) were screened by RT-PCR; the incidence of recurrent rearrangements was: ETV6-RUNX1, 12.9%; TCF3-PBX1, 5.0%; BCR-ABL1, 1.6%; and MLL rearrangements, 10.5%. STIL-TAL1 was detected in 22.7% of T-ALL cases. In B-ALL cases, the pEFS was significantly influenced by the presence of genetic alterations. RT-PCR studies improved patients' stratification and also the overall outcome of children treated in a pediatric hospital from a developing country.
本研究旨在确定阿根廷儿科急性淋巴细胞白血病(ALL)患者中复发性融合转录本的流行情况。通过 RT-PCR 对 380 名新诊断的儿童(包括 50 名婴儿和 44 名 T-ALL)进行了筛查;复发性重排的发生率为:ETV6-RUNX1,12.9%;TCF3-PBX1,5.0%;BCR-ABL1,1.6%;MLL 重排,10.5%。STIL-TAL1 在 22.7%的 T-ALL 病例中被检测到。在 B-ALL 病例中,基因改变的存在显著影响了无事件生存(EFS)。RT-PCR 研究改善了患儿的分层,也改善了发展中国家儿科医院治疗患儿的整体预后。